Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart D Katz

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Current Therapeutic Research, Clinical and Experimental|December 8, 2025
Pharmacodynamics, Safety, and Tolerability of Pyridostigmine Bromide in Heart FailureRandal Goldberg, Lucy Norcliffe-Kaufmann, Horacio Kaufmann, et al.
Contemporary Clinical Trials|September 5, 2017
The Healthy Hearts and Kidneys (HHK) study: Design of a 2×2 RCT of technology-supported self-monitoring and social cognitive theory-based counseling to engage overweight people with diabetes and chronic kidney disease in multiple lifestyle changesMary Ann Sevick, Kathleen Woolf, Aditya Mattoo, et al.
The New England Journal of Medicine|May 2, 2020
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19Harmony R Reynolds, Samrachana Adhikari, Claudia Pulgarin, et al.
American Heart Journal|September 1, 2014
Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient dataMarieke L Fokkema, Peter van der Meer, Sunil V Rao, et al.
Journal of Cardiac Failure|July 9, 2010
HFSA 2010 Comprehensive Heart Failure Practice Guideline, JoAnn Lindenfeld, Nancy M Albert, et al.
Journal of the American College of Cardiology|April 20, 2004
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure RegistryMarc Klapholz, Matthew Maurer, April M Lowe, et al.
Nature Communications|October 31, 2023
DIAPH1-MFN2 interaction regulates mitochondria-SR/ER contact and modulates ischemic/hypoxic stressGautham Yepuri, Lisa M Ramirez, Gregory G Theophall, et al.
Circulation. Heart Failure|May 20, 2025
Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine StudyHanyu Ni, Jinwen Cao, Daniel D Kinnamon, et al.
Circulation. Cardiovascular Imaging|April 22, 2020
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR GroupAna Carolina Alba, Juan Gaztañaga, Farid Foroutan, et al.
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Current Therapeutic Research, Clinical and Experimental|December 8, 2025
Pharmacodynamics, Safety, and Tolerability of Pyridostigmine Bromide in Heart FailureRandal Goldberg, Lucy Norcliffe-Kaufmann, Horacio Kaufmann, et al.
Contemporary Clinical Trials|September 5, 2017
The Healthy Hearts and Kidneys (HHK) study: Design of a 2×2 RCT of technology-supported self-monitoring and social cognitive theory-based counseling to engage overweight people with diabetes and chronic kidney disease in multiple lifestyle changesMary Ann Sevick, Kathleen Woolf, Aditya Mattoo, et al.
The New England Journal of Medicine|May 2, 2020
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19Harmony R Reynolds, Samrachana Adhikari, Claudia Pulgarin, et al.
American Heart Journal|September 1, 2014
Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient dataMarieke L Fokkema, Peter van der Meer, Sunil V Rao, et al.
Journal of Cardiac Failure|July 9, 2010
HFSA 2010 Comprehensive Heart Failure Practice Guideline, JoAnn Lindenfeld, Nancy M Albert, et al.
Journal of the American College of Cardiology|April 20, 2004
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure RegistryMarc Klapholz, Matthew Maurer, April M Lowe, et al.
Nature Communications|October 31, 2023
DIAPH1-MFN2 interaction regulates mitochondria-SR/ER contact and modulates ischemic/hypoxic stressGautham Yepuri, Lisa M Ramirez, Gregory G Theophall, et al.
Circulation. Heart Failure|May 20, 2025
Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine StudyHanyu Ni, Jinwen Cao, Daniel D Kinnamon, et al.
Circulation. Cardiovascular Imaging|April 22, 2020
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR GroupAna Carolina Alba, Juan Gaztañaga, Farid Foroutan, et al.
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Pageof 16